The bill boosts funding, speeds follow-on awards, and tightens national-security protections for SBIR/STTR—helping well-positioned small innovators—while creating risks of concentrated award distribution, new compliance and financing frictions, and added administrative burdens that may exclude or disadvantage some small firms.
Small businesses and startup R&D teams will get substantially more non-dilutive funding: SBIR set-aside increases, STTR increases, larger Phase II award ceilings (up to $30M) and expanded direct-to-Phase II authority for NIH/DOD.
Small businesses with promising technologies get faster and clearer paths to follow-on funding and government customers via direct-to-Phase II authority, required access to program/requirements offices, and expedited award deadlines for strategic breakthrough funds.
Researchers, startups, and agencies gain clearer statutory definitions and solicitation rules (SBIR/STTR/Phase terms, open-topic definitions, updated committee names), reducing legal ambiguity and administrative disputes across programs.
Small businesses, entrepreneurs, and investors may be blocked or deterred because broad foreign-tie denial grounds, long IP-transfer restrictions, and expanded agency discretion can bar otherwise-eligible firms and create opaque award decisions.
Many researchers, taxpayers, and other agency R&D programs could lose funding as larger SBIR/STTR set-asides and very large awards concentrate resources in fewer firms and reallocate agency R&D budgets away from other priorities.
Small firms face new operational and financial risks because firm-fixed-price contracting shifts more project risk onto awardees, and submission caps or limits on award counts can disadvantage companies that rely on multiple submissions.
Based on analysis of 14 sections of legislative text.
Raises SBIR/STTR set-asides, creates large 'strategic breakthrough' Phase II awards, caps cumulative awards, adds Phase 1A pilot, tightens foreign-risk screening, and requires new reporting.
Official title: To improve the SBIR and STTR programs under the Small Business Act, and for other purposes.
Introduced July 25, 2025 by Roger Williams · Last progress July 25, 2025
Increases required SBIR/STTR set-asides, creates a new "strategic breakthrough" funding stream that allows much larger Phase II awards, caps lifetime SBIR/STTR funding a single firm can receive, and adds new pilot Phase 1A awards and proposal limits. The bill also tightens foreign-risk disclosure and disqualification rules, authorizes direct-to-Phase II awards (with caps), and adds new reporting and procurement-data requirements to track award types. The changes take effect for fiscal year 2026 and thereafter for the funding floors and many program rules, and they impose new agency procedures for proposal handling, national-security screening, recordkeeping, and Federal Procurement Data System reporting.